Impact of vancomycin-resistant enterococci colonization in critically ill pediatric patients

American Journal of Infection Control

Volumn 44, Issue 5, 2016, Pages 515-519

  Sutcu, Murat ^a   Akturk, Hacer ^a   Acar, Manolya ^a   Salman, Nuran ^a   Aydin, Derya ^a   Akgun Karapinar, Bahar ^a   Ozdemir, Asli ^a   Cihan, Rukiye ^a   Citak, Agop ^a   Somer, Ayper ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

colonization; infection; pediatric intensive care unit; Vancomycin resistant enterococci

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; LINEZOLID; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLONE DERIVATIVE;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL COLONIZATION; BACTERIAL MENINGITIS; BACTERIUM DETECTION; BLOODSTREAM INFECTION; CASE CONTROL STUDY; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DISEASE COURSE; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM; FEMALE; HEALTHCARE ASSOCIATED INFECTION; HOSPITAL ADMISSION; HUMAN; INFECTION CONTROL; INFECTION RATE; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRESCHOOL CHILD; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; URINARY TRACT INFECTION; VANCOMYCIN RESISTANT ENTEROCOCCUS; BACTEREMIA; CRITICAL ILLNESS; EPIDEMIOLOGICAL MONITORING; GRAM POSITIVE INFECTION; HETEROZYGOTE; INFANT; ISOLATION AND PURIFICATION; MICROBIOLOGY; PEDIATRIC INTENSIVE CARE UNIT; RETROSPECTIVE STUDY;

BACTEREMIA; CARRIER STATE; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; CRITICAL ILLNESS; EPIDEMIOLOGICAL MONITORING; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INFANT; INTENSIVE CARE UNITS, PEDIATRIC; MALE; MENINGITIS, BACTERIAL; RETROSPECTIVE STUDIES; RISK FACTORS; URINARY TRACT INFECTIONS; VANCOMYCIN-RESISTANT ENTEROCOCCI;

EID: 84954495890     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2015.11.026     Document Type: Article

References (31)

1. R. Leclercq, E. Derlot, J. Duval, and P. Courvalin Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium N Engl J Med 319 1988 157 161
2. D.M. Sievert, P. Ricks, J.R. Edwards, A. Schneider, J. Patel, A. Srinivasan, and et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010 Infect Control Hosp Epidemiol 34 2013 1 14
3. European Centre for Disease Prevention and Control European Centre for Disease Prevention and Control Surveillance Report. Point prevalance survey of healthcare-associated infections and antimicrobial use in European hospitals, 2011-2012 2013 ECDC Stockholm, Sweden
4. M. Papadimitriou-Olivgeris, E. Drougka, F. Fligou, F. Kolonitsiou, A. Liakopoulos, V. Dodou, and et al. Risk factors for enterococcal infection and colonization by vancomycin-resistant enterococci in critically ill patients Infection 42 2014 1013 1022
5. M.J. Bonten, S. Slaughter, A.W. Ambergen, M.K. Hayden, J. van Voorhis, C. Nathan, and et al. The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable Arch Intern Med 158 1998 1127 1132
6. H. Humphreys Controlling the spread of vancomycin-resistant enterococci. Is active screening worthwhile? J Hosp Infect 88 2014 191 198
7. M. Morris-Downes, E.G. Smyth, J. Moore, T. Thomas, F. Fitzpatrick, J. Walsh, and et al. Surveillance and endemic vancomycin-resistant enterococci: some success in control is possible J Hosp Infect 75 2010 228 233
8. B.E. Murray Vancomycin-resistant enterococcal infections N Engl J Med 342 2000 710 721
9. M.A. Montecalvo, H. Horowitz, C. Gedris, C. Carbonaro, F.C. Tenover, A. Issah, and et al. Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit Antimicrob Agents Chemother 38 1994 1363 1367
10. M.C. Roghmann, R.J. McCarter Jr, J. Brewrink, A.S. Cross, and J.G. Morris Jr Clostridium difficile infection is a risk factor for bacteremia due to vancomycin-resistant enterococci (VRE) in VRE-colonized patients with acute leukemia Clin Infect Dis 25 1997 1056 1059
11. T.C. Horan, M. Andrus, and M.A. Dudeck CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting Am J Infect Control 36 2008 309 332
12. W.E. Trick, S.M. Paule, S. Cunningham, R.L. Cordell, M. Lankford, V. Stosor, and et al. Detection of vancomycin-resistant enterococci before and after antimicrobial therapy: use of conventional culture and polymerase chain reaction Clin Infect Dis 38 2004 780 786
13. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement M100-S22 Vol. 32 2012 CLSI Wayne (PA) No.3
14. Y.J. Kim, S.I. Kim, Y.R. Kim, J.Y. Lee, Y.J. Park, and Kang M.W. Risk factors for vancomycin-resistant enterococci infection and mortality in colonized patients on intensive care unit admission Am J Infect Control 40 2012 1018 1019
15. E. Jung, S. Byun, H. Lee, S.Y. Moon, and H. Lee Vancomycin-resistant Enterococcus colonization in the intensive care unit: clinical outcomes and attributable costs of hospitalization Am J Infect Control 42 2014 1062 1066
16. I.M. Zacharioudakis, F.N. Zervou, P.D. Ziakas, L.B. Rice, and E. Mylonakis Vancomycin-resistant enterococci colonization among dialysis patients: a meta-analysis of prevalence, risk factors, and significance Am J Kidney Dis 65 2015 88 97
17. M.A. Montecalvo, D.K. Shay, C. Gedris, C. Petrullo, J. Uman, K. Rodney, and et al. A semiquantitative analysis of the fecal flora of patients with vancomycin-resistant enterococci: colonized patients pose an infection control risk Clin Infect Dis 25 1997 929 930
18. B.J. Liss, J.J. Vehreschild, O.A. Cornely, M. Hallek, G. Fätkenheuer, H. Wisplinghoff, and et al. Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies Infection 40 2012 613 619
19. C.N. Olivier, R.K. Blake, L.L. Steed, and C.D. Salgado Risk of vancomycin-resistant Enterococcus (VRE) bloodstream infection among patients colonized with VRE Infect Control Hosp Epidemiol 29 2008 404 409
20. A. Kara, İ. Devrim, N. Bayram, N. Katipoǧlu, E. KIran, Y. Oruç, and et al. Risk of vancomycin-resistant enterococci bloodstream infection among patients colonized with vancomycin-resistant enterococci Braz J Infect Dis 19 2015 58 61
21. D. Kapur, D. Dorsky, J.M. Feingold, R.D. Bona, R.L. Edwards, J. Aslanzadeh, and et al. Incidence and outcome of vancomycin-resistant enterococcal bacteremia following autologous peripheral blood stem cell transplantation Bone Marrow Transplant 25 2000 147 152
22. D.M. Weinstock, M. Conlon, C. Iovino, T. Aubrey, C. Gudiol, E. Riedel, and et al. Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogeneic hematopoietic stem cell transplant Biol Blood Marrow Transplant 13 2007 615 621
23. M.J. Cohen, A. Adler, C. Block, I. Gross, N. Minster, V. Roval, and et al. Acquisition of vancomycin-resistant enterococci in internal medicine wards Am J Infect Control 37 2009 111 116
24. P.D. Ziakas, R. Thapa, L.B. Rice, and E. Mylonakis Trends and significance of VRE colonization in the ICU: a meta-analysis of published studies PLoS ONE 8 2013 e75658
25. B.E. Ostrowsky, L. Venkataraman, E.M. D'Agata, H.S. Gold, P.C. DeGirolami, and M.H. Samore Vancomycin-resistant enterococci in intensive care units: high frequency of stool carriage during a non-outbreak period Arch Intern Med 159 1999 1467 1472
26. L.L. Dever, C. China, R.H. Eng, C. O'Donovan, and W.G. Johanson Jr Vancomycin-resistant Enterococcus faecium in a Veterans Affairs Medical Center: association with antibiotic usage Am J Infect Control 26 1998 40 46
27. M.S. Whitman, P.G. Pitsakis, E. DeJesus, A.J. Osborne, M.E. Levison, and C.C. Johnson Gastrointestinal tract colonization with vancomycin-resistant Enterococcus faecium in an animal model Antimicrob Agents Chemother 40 1996 1526 1530
28. A.K. Zaas, Song X., P. Tucker, and T.M. Perl Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci Clin Infect Dis 35 2002 1139 1146
29. N.G. Tornieporth, R.B. Roberts, J. John, A. Hafner, and L.W. Riley Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients Clin Infect Dis 23 1996 767 772
30. R. Husni, R. Hachem, H. Hanna, and I. Raad Risk factors for vancomycin-resistant Enterococcus (VRE) infection in colonized patients with cancer Infect Control Hosp Epidemiol 23 2002 102 103
31. M.J. Matar, J. Tarrand, I. Raad, and K.V. Rolston Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer Am J Infect Control 34 2006 534 536